Volume 38, Issue 5

Search all Metabolic Brain Disease articles

June 2023

Includes Special Issue: Pathophysiology, diagnosis, and management of hepatic encephalopathy ( pages 1689 - 1768 )

Issue Editors:

Sara Montagnese,
Mette Munk Lauridsen

28 articles in this issue

Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics
Sahiti Chamarthy
Janaki Ramaiah Mekala
Review Article 24 April 2023 Pages: 1441 - 1469
Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways
Swesha Chhabra
Sidharth Mehan
Review Article 27 April 2023 Pages: 1471 - 1499
Do selenium-enriched foods provide cognitive benefit?
Ya-Zhi Bai
Shuang-Qing Zhang
Commentary 10 April 2023 Pages: 1501 - 1502
Effects of sesamin on Aβ_1-42-induced oxidative stress and LTP impairment in a rat model of Alzheimer's disease
Amir Arabi
Seyed Asaad Karimi
Alireza komaki
Original Article 27 February 2023 Pages: 1503 - 1511
Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine
Engy K. Tharwat
Ahmed O. Abdelaty
Nawal A. Ahmed
Original Article Open access 27 February 2023 Pages: 1513 - 1529
CircRNA-104718 promotes glioma malignancy through regulation of miR-218-5p/HMGB1 signalling pathway
Yunji Yan
Hongyu Wang
Yawen Pan
Original Article 03 March 2023 Pages: 1531 - 1542
Lactate dehydrogenase A mediated histone lactylation induced the pyroptosis through targeting HMGB1
Xuan Yao
Chao Li
Original Article 04 March 2023 Pages: 1543 - 1553
Elderberry diet improves gut-brain axis dysfunction, neuroinflammation, and cognitive impairment in the rat model of irritable bowel syndrome
Kosar Namakin
Meysam Hassani Moghaddam
Mohammad-Amin Abdollahifar
Original Article 06 March 2023 Pages: 1555 - 1572
Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters
Franciele Rabelo
Isabela da S. Lemos
Emilio Luiz Streck
Original Article 10 March 2023 Pages: 1573 - 1579
Necrostatin-1S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis
Kumari Preeti
Valencia Fernandes
Shashi Bala Singh
Original Article 10 March 2023 Pages: 1581 - 1612
Ferrous sulfate reverses cerebral metabolic abnormality induced by minimal hepatic encephalopathy
Xue-Fei Liu
Jing-Jing Lu
Jin-Wei Qiang
Original Article 14 March 2023 Pages: 1613 - 1620
Hsa_circ_0001361 facilitates cell progression and glycolytic metabolism in neuroblastoma via interacting with mir-490-5p to induce TRIM2 upregulation
Rongrong Lv
Fang Lu
Shanshan Xu
Original Article 15 March 2023 Pages: 1621 - 1632
Stellate ganglion block suppresses hippocampal ferroptosis to attenuate cerebral ischemia-reperfusion injury via the Hippo pathway
Chunwang Zhou
Mengyuan Li
Ping Gao
Original Article 16 March 2023 Pages: 1633 - 1642
Irisin attenuates ethanol-induced behavioral deficits in mice through activation of Nrf2 and inhibition of NF-κB pathways
Xi Jiang
Qizhi Yan
Fuhe Liu
Original Article 22 March 2023 Pages: 1643 - 1656
Morus alba fruit diet ameliorates cognitive deficit in mouse model of streptozotocin-induced memory impairment
Parul Sood
Varinder Singh
Richa Shri
Original Article 22 March 2023 Pages: 1657 - 1669
Administration of growth hormone ameliorates adverse effects of total sleep deprivation
Parisa Arvin
Samireh Ghafouri
Yaghoub Farbood
Original Article 02 March 2023 Pages: 1671 - 1681
Correction to: Administration of growth hormone ameliorates adverse effects of total sleep deprivation
Parisa Arvin
Samireh Ghafouri
Yaghoub Farbood
Correction 20 April 2023 Pages: 1683 - 1683
Correction to: Celastrus paniculatus oil ameliorates NF-KB mediated neuroinflammation and synaptic plasticity in the scopolamine-induced cognitive impairment rat model
Khushboo Govind Faldu
Snehal Sanjay Patel
Jigna Samir Shah
Correction 24 April 2023 Pages: 1685 - 1687
Special Issue: Pathophysiology, diagnosis, and management of hepatic encephalopathy
Sara Montagnese
Mette Munk Lauridsen
Editorial 11 May 2023 Pages: 1689 - 1690
Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?
Simon Johannes Gairing
Eva Maria Schleicher
Christian Labenz
Review Article Open access 24 August 2022 Pages: 1691 - 1700
Predicting which patients with cirrhosis will develop overt hepatic encephalopathy: Beyond psychometric testing
Zachary M. Saleh
Elliot B. Tapper
Review Article 29 October 2022 Pages: 1701 - 1706
The role of brain inflammation and abnormal brain oxygen homeostasis in the development of hepatic encephalopathy
Anne Catrine Daugaard Mikkelsen
Karen Louise Thomsen
Anna Hadjihambi
Review Article 03 November 2022 Pages: 1707 - 1716
Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?
Wim Laleman
Michael Praktiknjo
Geert Maleux
Review Article 19 November 2022 Pages: 1717 - 1728
Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate
Silvia Nardelli
Daniele Bellafante
Stefania Gioia
Review Article 29 November 2022 Pages: 1729 - 1736
Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge
Adam P. Buckholz
Russell Rosenblatt
Review Article 12 December 2022 Pages: 1737 - 1747
Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis
Archita P. Desai
Devika Gandhi
Eric S. Orman
Original Article 19 December 2022 Pages: 1749 - 1758
Albumin therapy for hepatic encephalopathy: current evidence and controversies
Yu Jun Wong
Jing Hong Loo
Short Communication 26 May 2022 Pages: 1759 - 1763
Hypokalaemia – an active contributor to hepatic encephalopathy?
Anne Catrine Daugaard Mikkelsen
Karen Louise Thomsen
Niels Kristian Aagaard
Short Communication 03 November 2022 Pages: 1765 - 1768

Volume 38, Issue 5

Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics

Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways

Do selenium-enriched foods provide cognitive benefit?

Effects of sesamin on Aβ_1-42-induced oxidative stress and LTP impairment in a rat model of Alzheimer's disease

Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine

CircRNA-104718 promotes glioma malignancy through regulation of miR-218-5p/HMGB1 signalling pathway

Lactate dehydrogenase A mediated histone lactylation induced the pyroptosis through targeting HMGB1

Elderberry diet improves gut-brain axis dysfunction, neuroinflammation, and cognitive impairment in the rat model of irritable bowel syndrome

Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters

Necrostatin-1S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis

Ferrous sulfate reverses cerebral metabolic abnormality induced by minimal hepatic encephalopathy

Hsa_circ_0001361 facilitates cell progression and glycolytic metabolism in neuroblastoma via interacting with mir-490-5p to induce TRIM2 upregulation

Stellate ganglion block suppresses hippocampal ferroptosis to attenuate cerebral ischemia-reperfusion injury via the Hippo pathway

Irisin attenuates ethanol-induced behavioral deficits in mice through activation of Nrf2 and inhibition of NF-κB pathways

Morus alba fruit diet ameliorates cognitive deficit in mouse model of streptozotocin-induced memory impairment

Administration of growth hormone ameliorates adverse effects of total sleep deprivation

Correction to: Administration of growth hormone ameliorates adverse effects of total sleep deprivation

Correction to: Celastrus paniculatus oil ameliorates NF-KB mediated neuroinflammation and synaptic plasticity in the scopolamine-induced cognitive impairment rat model

Special Issue: Pathophysiology, diagnosis, and management of hepatic encephalopathy

Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Predicting which patients with cirrhosis will develop overt hepatic encephalopathy: Beyond psychometric testing

The role of brain inflammation and abnormal brain oxygen homeostasis in the development of hepatic encephalopathy

Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?

Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate

Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge

Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis

Albumin therapy for hepatic encephalopathy: current evidence and controversies

Hypokalaemia – an active contributor to hepatic encephalopathy?

Navigation